AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAR 4 - (NewsRx.com & NewsRx.net) -- TNP-470 blocks carcinosarcoma-induced tube formation.
According to researchers in Japan, "we evaluated the usefulness of TNP-470 as an anticancer agent on a human uterine carcinosarcoma cell line (FU-MMT-1). FU-MMT-1 induced human arterial endothelial cell (HAEC) tube formation on an in vitro cocultured model of FU-MMT-1 and HAECs on a matrix gel, and was blocked by vascular endothelial growth factor (VEGF)-2 receptor (KDR/Flk-1) tyrosine inhibitor. Lower concentration of TNP-470 inhibited the tube formation."
"Cell proliferation of FU-MMT-1 but not HAEC was inhibited by lower concentration of TNP-470. In addition, lower concentration of TNP-470 blocked VEGF production on FU-MMT-1," wrote S. Miura and colleagues, Fukuoka University, School of Medicine.
"Our results suggest that TNP-470 directly inhibited FU-MMT-1 but not HAEC growth accompanied with the ...
Source: HighBeam Research, TNP-470 blocks carcinosarcoma-induced tube formation.